Oxford BioDynamics Income Statement

Financials in millions GBP. Fiscal year is October - September.

Millions GBP. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Revenue	1.1	0.64	0.51	0.15	0.34
Revenue Growth (YoY)	72.17%	24.71%	231.17%	-54.84%	-25.22%
Cost of Revenue	0.57	0.35	0.24	0.04	-
Gross Profit	0.52	0.29	0.27	0.12	0.34
Selling, General & Admin	8.98	9.97	8.81	6.94	5.62
Research & Development	0.62	0.81	0.76	0.53	0.9
Other Operating Expenses	-0.03	-0.48	-0.83	-0.35	-0
Operating Expenses	11.27	12.29	10.43	8.72	7.85
Operating Income	-10.75	-12	-10.17	-8.6	-7.51
Interest Expense	-0.31	-0.23	-0.21	-0.2	-0.11
Interest & Investment Income	0.06	0.11	0.07	0.01	0.03
Currency Exchange Gain (Loss)	-0.11	-0.3	0.03	0.12	-0.03
Other Non Operating Income (Expenses)	0.01	1.35	-1.25	1.1	-
EBT Excluding Unusual Items	-11.1	-11.06	-11.52	-7.57	-7.63
Gain (Loss) on Sale of Assets	-	-	0.11	-	-
Asset Writedown	-0.33	-0.9	-	-	-
Pretax Income	-11.42	-11.96	-11.41	-7.57	-7.63
Income Tax Expense	-0.27	-0.39	-0.59	-0.86	-0.95
Net Income	-11.15	-11.57	-10.83	-6.71	-6.68
Net Income to Common	-11.15	-11.57	-10.83	-6.71	-6.68
Shares Outstanding (Basic)	1,387	256	147	100	93
Shares Outstanding (Diluted)	1,387	256	147	100	93
Shares Change (YoY)	442.40%	73.40%	47.92%	7.72%	-
EPS (Basic)	-0.01	-0.05	-0.07	-0.07	-0.07
EPS (Diluted)	-0.01	-0.05	-0.07	-0.07	-0.07
Free Cash Flow	-7.59	-10.25	-8.54	-5.54	-8.61
Free Cash Flow Per Share	-0.01	-0.04	-0.06	-0.06	-0.09
Gross Margin	47.67%	45.44%	52.16%	75.33%	100.00%
Operating Margin	-981.46%	-1886.48%	-1993.72%	-5585.07%	-2202.93%
Profit Margin	-1018.54%	-1818.71%	-2122.74%	-4357.14%	-1959.53%
Free Cash Flow Margin	-693.15%	-1611.95%	-1675.29%	-3597.40%	-2525.22%
EBITDA	-10.27	-11.33	-9.51	-8	-6.86
D&A For EBITDA	0.48	0.67	0.66	0.61	0.65
EBIT	-10.75	-12	-10.17	-8.6	-7.51

Source: S&P Global Market Intelligence. Standard template. Financial Sources.